Introduction: The gut microbiota is a key component of the gut-brain axis, and its dysbiosis promotes neuroinflammation. The microbiome plays a significant role in the pathogenesis of neurodegenerative diseases. This article focuses on Alzheimer's and Parkinson's diseases. Materials and methods: PubMed and Google Scholar databases were searched using the keywords: "gut microbiota," "neurodegenerative diseases," "probiotics," and "fecal microbiota transplantation." A selection of relevant materials was then analyzed. Aim of the study: The aim of this study is to investigate the impact of the gut microbiota on the development of neurodegenerative diseases, with a particular focus on Parkinson's and Alzheimer's, and to explore the possibility of slowing their progression or improving their treatment by subjecting the microbiota to change. Description of the state of knowledge: Targeting the gut microbiota represents a novel avenue for managing NDDs. Therapeutic strategies focusing on microbiota modulation, including probiotics and FMT, show significant potential. Further research is essential to validate these approaches and optimize personalized treatments for AD and PD. Results: Gut microbiota dysbiosis was found to significantly contribute to the progression of AD and PD diseases by promoting neuroinflammation, disrupting the blood-brain barrier, and altering neurotransmitter levels. Probiotics, particularly Lactobacillus and Bifidobacterium strains and FMT showed potential in restoring microbial balance and reducing inflammation and improved cognitive and motor functions. Despite these promising findings, clinical evidence remains limited, and further research is necessary.
Background: Atherosclerosis is a degenerative-proliferative disease that leads to lesions primarily in the tunica intima and media of the arteries. Atherosclerotic plaques undergo progressive calcification, and the hydroxyapatite deposited within them absorbs X-rays. The coronary artery calcification score (CAC-score) can be assessed using computed tomography. Intima–media thickness (IMT) and endothelial function, evaluated by flow-mediated dilatation (FMD) of the brachial artery, can be measured using ultrasound. This study aimed to assess the relationship between CAC-score, atherosclerosis risk factors, IMT, and FMD in women, with particular emphasis on the comparison of IMT measurement sites. Methods: The study included 124 women divided into three groups based on CAC-score. The following parameters were evaluated: risk factors for coronary artery disease (CAD), FMD, and IMT. CAD risk factors included age, BMI, smoking status, hypertension, diabetes, and lipid disorders, which were obtained from medical history. Results: A significant positive correlation was observed between CAC-score and IMT of the common carotid artery in women. IMT measured at the carotid bifurcation showed the strongest correlation with CAC-score. No correlation was found between CAC-score and endothelial dysfunction assessed by FMD. Conclusions: IMT, particularly when measured at the carotid bifurcation, was associated with CAC-score in women without diagnosed CAD, whereas no association was observed between FMD and CAC-score in this population.
26 May 2026 in International Journal of Innovative Technologies in Social Science
Introduction: Mobile phone addiction has become a very common phenomenon among young people. It leads to a number of negative consequences for their health, both physical and mental. The aim of this paper is to present the most important consequences of excessive phone use in terms of mental health, such as depression, anxiety and feelings of loneliness. Issues such as the impact of phone addiction on sleep disorders, orthorexia and eating behaviour are also discussed. The paper highlights that excessive use of mobile devices can significantly affect the quality of life of young people, contributing to emotional disturbances and reduced psychological well-being. Conclusions point to the need for further research and educational activities to reduce the negative impact of this phenomenon. Methodology: For this work, we conducted a search in the PubMed and Google Scholar databases using the keywords: "phone addiction," " health," " lifestyle," " mental wellbeing" followed by an analysis of the selected materials. Aim of the study: The aim of this work is to analyse the impact of smartphone addiction on young people's mental health, with a focus on aspects such as depression, anxiety, sleep disorders, orthorexia, social relationships and feelings of loneliness. Conclusion: Excessive use of mobile devices can have a significant impact on the quality of life of young people, contributing to emotional, sleep and eating disorders. Preventive measures are advisable, including education on sleep hygiene, limiting the time spent in front of screens before bedtime and promoting healthy lifestyles among young people and students.
22 September 2026 in International Journal of Innovative Technologies in Social Science
Cancer is one of the leading causes of death, following cardiovascular diseases. Despite significant advances in medicine, cancer incidence continues to rise, with the number of affected individuals having doubled over the past decades. Pain is the most common symptom experienced during the course of cancer. On average, approximately half of patients with cancer, at various stages of the disease, suffer from pain. According to the concept proposed by Cicely Saunders, founder of St Christopher’s Hospice in London, cancer pain is a multidimensional and overwhelming experience referred to as “total pain” which includes physical, psychological, social, and spiritual components. The aim of this study is to present the issue of pain in the course of cancer, to define appropriate nursing management strategies for the assessment and monitoring of this symptom, and to provide a descriptive analysis of current knowledge on pain and its treatment. This paper is based on a review of the relevant literature, including textbooks, scientific articles, and current legal regulations. It consists of three chapters addressing palliative care, the characteristics of cancer pain, and principles of nursing management in its assessment and control.
20 December 2024 in Journal of Education, Health and Sport
Introduction: Caffeine is one of the most frequently used psychostimulants in the world. It is present in many drinks consumed around the world. Its stimulating effect on the central nervous system has been known for years. Moreover, many athletes take it before competitions to achieve better results. The aim of this study is to present the effect of caffeine on cognitive abilities, sleep and performance in sports. Material and methods: We searched for materials for this work in the Pubmed and Google Scholar databases using the keywords: "caffeine", "caffeine sport", "caffeine sleep", "caffeine brain", "caffeine side effects". Then we analyzed the selected materials. Aim of the study: The effect of caffeine on cognitive abilities, sleep and sports performance. Conclusion: Caffeine helps improve concentration and attention, increases physical performance, supports short-term memory, and may also improve mood by stimulating the production of dopamine. However, you should pay attention to the side effects of its use and withdrawal syndrome.
4 May 2026 in International Journal of Innovative Technologies in Social Science
Vericiguat is the first oral soluble guanylate cyclase (sGC) stimulator developed to reduce the risk of cardiovascular death and heart failure–related hospitalizations in patients with chronic heart failure with reduced left ventricular ejection fraction (HFrEF). sGC dysfunction, resulting in impaired synthesis of cyclic guanosine monophosphate (cGMP), may play a keyrole in the pathophysiology of heart failure by affecting myocardial function, vascular tone, and peripheral tissue perfusion. Vericiguat exerts its therapeutic effect by enhancing intracellular cGMP levels, leading to improved cardiac function and vasodilation. Consequently, the drug represents a promising treatment option for patients with HFrEF, particularly those with recent decompensation, requiring intravenous diuretic therapy, or at high risk for rehospitalization due to disease exacerbation. Clinical efficacy of vericiguat was demonstrated in the VICTORIA trial, which enrolled 6,857 patients with HFrEF following recent decompensation. After a median follow-up of 10.8 months, treatment with vericiguat significantly reduced the risk of the composite endpoint of cardiovascular death or heart failure related hospitalization compared with placebo. Patients with more advanced disease also exhibited reductions in NT-proBNP levels, suggesting a potential biomarker of therapeutic response. Vericiguat is generally well tolerated. The most commonly reported adverse events are hypotension and syncope. The drug can be safely administered to patients with mild to moderate renal or hepatic impairment, although data in severe organ dysfunction are lacking. Dose adjustments are not required based on age or body weight. The introduction of vericiguat into the management of HFrEF represents a meaningful advancement in therapy. While the drug does not significantly extend overall survival, its use is associated with a substantial reduction in the risk of recurrent hospitalizations, which may have important clinical and prognostic implications in this patient population.